Tesmilifene - Chemopotentiator for Cancer Therapies
Key Data:
Drug (brand / generic)
Tesmilifene
Company / licensee
YM BioSciences Inc
Therapy class
Chemopotentiator
Product description
Small molecule which boosts activity of standard cytotoxic agents such as anthracyclines
Current indication
Breast cancer
Market sector
Oncology
Development status
Phase III trial stopped early
